Navigation Links
The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
Date:3/18/2009

LONDON, March 18 /PRNewswire/ -- Despite the initial regulatory hiccups, the number of biosimilars in the European market is set to increase gradually. The patent expiry of key biopharmaceuticals has opened up numerous lucrative market opportunities, while driving the development of biosimilars. In addition, payers' perception of biosimilars, as viable alternatives to originator drugs due to their safety, efficacy and affordability, will further bolster market prospects.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"Patent expiries of some top selling biopharmaceuticals have resulted in a massive market opportunity for biosimilar manufacturers," notes Frost & Sullivan Senior Research Analyst Sumanth Kambhammettu. "Product classes such as erythropoietins, insulin and analogs, granulocyte colony-stimulating factors, human growth hormones and interferons, which have all lost patent protection, had a collective market size of approximately $34.04 billion in 2007."

If you are interested in a virtual brochure for the latest analysis from Frost & Sullivan (http://www.pharma.frost.com) titled, European Biosimilars Market Outlook, which provides manufacturers, end users and other industry participants with an overview of the study, send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com. Please include your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

Expensive biopharmaceuticals are used primarily
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. BIOLOCK(TM) USA Launches Affordable Fingerprint door Locks for Homes and Offices
2. DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season
3. ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments
4. Secretropin(R) - Effective, Preferable, Affordable as an Alternative to Injectable Growth Hormone - Gains Momentum
5. Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
10. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
11. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Israel, December 2 Gamida Cell announced today,a ... and,efficacy of a gene therapy product which combines ... The product may have potential to,treat inherited anemias ... Gamida Cell is developing a series of ...
(Date:12/2/2009)... -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: ... in the development, manufacturing, and marketing of branded,generic ... 105 of,its drugs have been included in China,s ... China,s Ministry of Human Resources and Social,Security on ...
(Date:12/2/2009)... life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among ... ... (PRWEB) December 2, 2009 -- The ... designer and manufacturer of high-performance CCD and EMCCD cameras for ...
(Date:12/1/2009)... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... of approximately $57 million, as compared with $69 million for ... results was the first of two installment payments of $12.5 ... results was a one-time $1.8 million payment from Genentech for ...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
... China, May 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech ... device research,and development outsourcing company with operations ... announced that it has appointed Dr. Peng ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Prior ...
... In Europe, Less Screening and Treatment, and an Apparent Higher ... of Hip Fracture Than in North America and Australia, ... one in four women surveyed from Europe, North America, and,Australia ... of 45,years. Among women considered to be at high risk ...
... Inc. (Nasdaq:,BHRT) announced that on May 21, 2008 ... (the "Nasdaq Letter") advising that, for the last ... listed securities,had been below the minimum $50,000,000 requirement ... to Nasdaq Marketplace Rule,4450(b)(1)(A). Furthermore, Nasdaq stated that ...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 3Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 4Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 2
(Date:12/3/2009)... to learn new information and adapt to changes in our ... to lie in the minute junctions where nerve cells communicate, ... researchers. The study is published online this week in the ... Wen-Biao Gan, PhD, associate professor of physiology and neuroscience at ...
(Date:12/3/2009)... infections are caused by many bacterial cells that signal each ... sensing because many bacteria must be present to start the ... that the very first stage of staph infection, when bacteria ... a single cell and that this individual process can be ...
(Date:12/3/2009)... measured CO2 levels for the past three years in ... area near Valladolid. The results, which are the first ... the levels rose "significantly" between 2002 and 2005. , ... to find out about carbon dioxide (CO2) levels, and ...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 1The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 2The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 3The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 4The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 5Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 1Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 2Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 3Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 1Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 2Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 3Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 4
... McKnight Brain Institute of the University of Florida have ... diseases by plundering the secrets of regeneration from creatures ... starfish and flatworms. , Fueled by about $6 million ... "The Regeneration Project" will connect scientists who work with ...
... medical practice that an antiretroviral drug widely used to treat ... own in patients co-infected with HIV. Their findings demonstrate ... drugs used to treat the AIDS virus. , "Our results ... has been shown to be active against HIV - it ...
... snakes are born with poisonous bites they use for defense. ... , What if they could borrow a dose of poison ... That's exactly what happens in the relationship between an Asian ... of researchers funded by the National Science Foundation (NSF) Division ...
Other Biology News:Research project tackles 'regeneration' gap 2Research project tackles 'regeneration' gap 3Widely used hepatitis B drug spurs HIV drug resistance 2Widely used hepatitis B drug spurs HIV drug resistance 3Nonvenomous Asian snakes 'borrow' defensive poison from toxic toads 2
... Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... DNA polymerase is an antibody-mediated ... both conventional and real-time PCR ... at a concentration of 5 ... 5,000 units polymerase, 25 ml ...
... the formation of a phosphodiester bonds between ... duplex DNA molecules or between oligonucleotides which ... at 45 - 65?. Tfi DNA Ligase ... temperatures than conventional DNA ligases, Thus, Tfi ...
... GELase™ Agarose Gel-Digesting Preparation contains a unique ... simple, quantitative recovery of intact DNA and ... gels following electrophoresis in TAE, TBE, MOPS, ... digested directly in the TAE, TBE, MOPS, ...
Biology Products: